Results 241 to 250 of about 6,399,825 (302)

Dendritic-Cell Tumor Vaccines

Transplantation Proceedings, 2010
Most cancers remain incurable. Introduction of novel therapeutic methods, including new cytostatic regimens and targeted therapies, such as monoclonal antibodies and tyrosine kinase inhibitors, have increased remission rates as well as improved patient survival, but the ability to cure many cancer patients remains elusive.
J, Rolinski, I, Hus
openaire   +2 more sources

Tumor Cell Vaccines

2007
This chapter reviews the history of tumor cell vaccines, both autologous and allogeneic, as well as adjuvants used with tumor cell vaccines. The chapter discusses various tumor cell modifications that have been tested over the years. The immune response to tumor vaccines is briefly described, as are some methods of immune monitoring after vaccine ...
Patricia L, Thompson   +1 more
openaire   +2 more sources

Dendritic cell based tumor vaccines

Immunology Letters, 2000
Dendritic cells (DC) constitute a unique system of cells that induce, sustain and regulate immune responses. Distributed as sentinels throughout the body, DC are poised to capture antigen (Ag), migrate to draining lymphoid organs, and, after a process of maturation, select Ag-specific lymphocytes to which they present the processed Ag, thereby inducing
M, Nouri-Shirazi   +3 more
openaire   +2 more sources

Cytokine-secreting tumor cell vaccines

Current Opinion in Immunology, 2000
Modification of the tumor microenvironment with gene transfer techniques stimulates two immune mechanisms that effectuate tumor destruction. One involves improved tumor-antigen presentation for the development of specific cellular and humoral immunity. The second involves compromise of the tumor vasculature by soluble factors and leukocytes.
Mach, Nicolas, Dranoff, G
openaire   +3 more sources

Home - About - Disclaimer - Privacy